In Vitro Activity of Fluoroquinolones against Mycoplasma genitalium and Their Bacteriological Efficacy for Treatment of M. genitalium-Positive Nongonococcal Urethritis in Men

This publication has 13 references indexed in Scilit:

• In Vitro Activities of the Newer Quinolones Garenoxacin, Gatifloxacin, and Gemifloxacin against Human Mycoplasmas
  Antimicrobial Agents and Chemotherapy, 2004
• ComparativeIn Vitro Susceptibilities and Bactericidal Activities ofInvestigational Fluoroquinolone ABT-492 and Other Antimicrobial Agentsagainst Human Mycoplasmas andUreaplasmas
  Antimicrobial Agents and Chemotherapy, 2003
• Association of Mycoplasma genitalium Persistence in the Urethra With Recurrence of Nongonococcal Urethritis
  Sexually Transmitted Diseases, 2001
• In Vitro Activity of Trovafloxacin Compared to Those of Five Antimicrobials against Mycoplasmas Including Mycoplasma hominis and Ureaplasma urealyticum Fluoroquinolone-Resistant Isolates That Have Been Genetically Characterized
  Antimicrobial Agents and Chemotherapy, 2000
• Comparative Activities of Telithromycin (HMR 3647), Levofloxacin, and Other Antimicrobial Agents against Human Mycoplasmas
  Antimicrobial Agents and Chemotherapy, 2000
• Occurrence and treatment of Mycoplasma genitalium in patients visiting STD clinics in Sweden
  International Journal of STD & AIDS, 2000
• Comparative potency of gemifloxacin, new quinolones, macrolides, tetracycline and clindamycin against Mycoplasma spp.
  Journal of Antimicrobial Chemotherapy, 2000
• In vitro activity of gemifloxacin (SB 265805; LB20304a) against human mycoplasmas
  Journal of Antimicrobial Chemotherapy, 2000
• In-vitro activity of grepafloxacin, a new fluoroquinolone, against mycoplasmas.
  Journal of Antimicrobial Chemotherapy, 1999
• In vitro susceptibilities of Mycoplasma genitalium to antibiotics
  Antimicrobial Agents and Chemotherapy, 1992